Pan American Health Organization, Health Emergencies Department, Washington, Columbia, United States of America.
Pan American Health Organization, Incident Management Systems for COVID-19, Washington, Columbia, United States of America.
PLoS One. 2021 Apr 28;16(4):e0250708. doi: 10.1371/journal.pone.0250708. eCollection 2021.
Coronavirus disease (COVID-19) is the pandemic caused by SARS-CoV-2 that has caused more than 2.2 million deaths worldwide. We summarize the reported pathologic findings on biopsy and autopsy in patients with severe/fatal COVID-19 and documented the presence and/or effect of SARS-CoV-2 in all organs.
A systematic search of the PubMed, Embase, MedRxiv, Lilacs and Epistemonikos databases from January to August 2020 for all case reports and case series that reported histopathologic findings of COVID-19 infection at autopsy or tissue biopsy was performed. 603 COVID-19 cases from 75 of 451 screened studies met inclusion criteria. The most common pathologic findings were lungs: diffuse alveolar damage (DAD) (92%) and superimposed acute bronchopneumonia (27%); liver: hepatitis (21%), heart: myocarditis (11.4%). Vasculitis was common only in skin biopsies (25%). Microthrombi were described in the placenta (57.9%), lung (38%), kidney (20%), Central Nervous System (CNS) (18%), and gastrointestinal (GI) tract (2%). Injury of endothelial cells was common in the lung (18%) and heart (4%). Hemodynamic changes such as necrosis due to hypoxia/hypoperfusion, edema and congestion were common in kidney (53%), liver (48%), CNS (31%) and GI tract (18%). SARS-CoV-2 viral particles were demonstrated within organ-specific cells in the trachea, lung, liver, large intestine, kidney, CNS either by electron microscopy, immunofluorescence, or immunohistochemistry. Additional tissues were positive by Polymerase Chain Reaction (PCR) tests only. The included studies were from numerous countries, some were not peer reviewed, and some studies were performed by subspecialists, resulting in variable and inconsistent reporting or over statement of the reported findings.
The main pathologic findings of severe/fatal COVID-19 infection are DAD, changes related to coagulopathy and/or hemodynamic compromise. In addition, according to the observed organ damage myocarditis may be associated with sequelae.
由严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)引起的冠状病毒病(COVID-19)是一种全球性大流行疾病,已导致全球 220 多万人死亡。我们总结了严重/致命 COVID-19 患者活检和尸检的报告病理发现,并记录了 SARS-CoV-2 在所有器官中的存在和/或作用。
从 2020 年 1 月至 8 月,我们对 PubMed、Embase、MedRxiv、Lilacs 和 Epistemonikos 数据库进行了系统检索,以查找所有报告 COVID-19 感染尸检或组织活检组织病理学发现的病例报告和病例系列。对 75 项从 451 项筛查研究中筛选出的研究进行了评估,其中 603 例 COVID-19 病例符合纳入标准。最常见的病理发现是肺部:弥漫性肺泡损伤(DAD)(92%)和急性支气管肺炎(27%);肝脏:肝炎(21%),心脏:心肌炎(11.4%)。血管炎仅见于皮肤活检(25%)。微血栓在胎盘(57.9%)、肺(38%)、肾(20%)、中枢神经系统(CNS)(18%)和胃肠道(GI)道(2%)中均有描述。肺(18%)和心脏(4%)的内皮细胞损伤很常见。缺氧/灌注不足、水肿和淤血引起的血运变化在肾脏(53%)、肝脏(48%)、CNS(31%)和胃肠道(18%)中很常见。通过电子显微镜、免疫荧光或免疫组化,在气管、肺、肝、大肠、肾、CNS 等器官的特定细胞中均证实存在 SARS-CoV-2 病毒颗粒,聚合酶链反应(PCR)检测仅使其他组织呈阳性。纳入的研究来自许多国家,有些未经过同行评审,有些研究由亚专科医生进行,导致报告结果存在差异且不一致,或夸大了报告结果。
严重/致命 COVID-19 感染的主要病理发现是 DAD、与凝血功能障碍和/或血运障碍相关的变化。此外,根据观察到的器官损伤,心肌炎可能与后遗症有关。